mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.7 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |